Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astaxanthin in Moderate to Severe Knee Osteoarthritis
NCT05437601Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of astaxanthin in osteoarthritis (OA), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jul 2022; status: completed.
02
Drugs
astaxanthin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05437601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05437601.